Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
Products
Products
Diseases
News
«
1
2
...
8
9
10
11
12
13
14
15
16
17
18
...
27
28
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
283
566
849
1132
1415
1698
1981
2264
2547
2830
CN1
/ Curon Biopharma
CNTY-101
/ Century Therap
CT120
/ IASO BIO
Combotox
(Imtox19/Imtox22) / Montefiore Medical Center, National Cancer Institute, Abiogen
DCSZ11
/ DynamiCure Biotech
DSP-107
/ Kahr Medical
Delito
(rituximab biosimilar) / Sino Biopharm
Duoc-01
/ Duke University Medical Center
EBV-specific anti-PD1Â TCR-TÂ cells
/ TCRCure
ESG206
/ Escugen Biotechnology
ETH-155008
/ Shengke Pharmaceuticals
EU101
/ Eutilex
F007
(rituximab biosimilar) / Lunan Pharma
FFP104
/ FF Pharma
FH-2001
/ Fosun Pharma
FPT155
/ Amgen
FS118
/ Sino Biopharm
FT819
/ Fate Therap, Memorial Sloan-Kettering Cancer Center
FYB206
(pembrolizumab biosimilar) / Formycon
GB1275
/ Gossamer Bio
GB241
(rituximab biosimilar) / Nanjing Yoko Biomedical, Walvax
GC007G
/ AstraZeneca
GEN1044
/ Genmab, AbbVie
GEN1047
/ Genmab
GEN3014
/ Genmab, J&J
GLPG5101
/ Galapagos
GMI-1359
/ GlycoMimetics
GP40141
(romiplostim biosimilar) / Geropharm
GSK4381562
/ GSK
HB0025
/ Zhejiang Huahai Pharma
HB0045
/ Zhejiang Huahai Pharma
HLX301
/ Fosun Pharma
HS-10342
/ Jiangsu Hansoh Pharma
Halpryza
(rituximab biosimilar) / Innovent Biologics, Eli Lilly
Human tyrosinase DNA Vaccine
/ Ingro Finanz
IBI-323
/ Innovent Biologics
IBI-389
/ Innovent Biologics
IBR733
/ Imbioray Bio
IMA203CD8
/ Immatics
IMC002
/ Immuneoncia Therap
IMJ995
/ Novartis
IMU-201
/ Imugene
IO-202
/ Immune-Onc Therap
ISB 1302
/ Harbour BioMed, Glenmark
ISB 1442
/ Glenmark
JD023
/ Beijing JD Biotech
JNJ-26366821
/ J&J
JNJ-4703
/ J&J
JR-441
/ JCR Pharma
JS019
/ Suzhou Kebo Ruijun Bio
«
1
2
...
8
9
10
11
12
13
14
15
16
17
18
...
27
28
»
